CareDx - CDNA Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares.
View CDNA analyst ratings or view top-rated stocks.

5 equities research analysts have issued 12-month target prices for CareDx's shares. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they anticipate the company's share price to reach $16.00 in the next year. This suggests a possible upside of 76.2% from the stock's current price.
View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts.

CareDx's stock was trading at $11.41 at the start of the year. Since then, CDNA stock has decreased by 20.4% and is now trading at $9.08.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our CDNA earnings forecast.

CareDx, Inc (NASDAQ:CDNA) released its earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.21. The company earned $75.60 million during the quarter, compared to analysts' expectations of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 17.33% and a negative net margin of 23.81%. CareDx's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter last year, the company earned ($0.06) EPS.

ETFs with the largest weight of CareDx (NASDAQ:CDNA) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), Jacob Forward ETF (JFWD), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Global X Genomics & Biotechnology ETF (GNOM), SPDR S&P Biotech ETF (XBI), Direxion Daily S&P Biotech Bull 3x Shares (LABU), Principal Healthcare Innovators ETF (BTEC) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

CareDx issued an update on its FY 2023 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $328.00 million-$338.00 million, compared to the consensus revenue estimate of $338.42 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

CareDx's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (11.56%), ArrowMark Colorado Holdings LLC (7.48%), Sumitomo Mitsui Trust Holdings Inc. (4.79%), Nikko Asset Management Americas Inc. (4.79%), Bamco Inc. NY (3.84%) and Gagnon Securities LLC (2.79%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends.

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDNA stock can currently be purchased for approximately $9.08.

CareDx (NASDAQ:CDNA) has a market capitalization of $487.32 million and generates $321.79 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

The company employs 633 workers across the globe.

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.